Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fibroses, Pulmonary”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01349192
What this trial is testing

Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF)

Who this might be right for
Cystic FibrosisMethicillin-resistant Staphylococcus Aureus
University of North Carolina, Chapel Hill 47
Not applicableUnknownNCT03859531
What this trial is testing

Gastrointestinal Study at Orkambi Therapy in CF Patients

Who this might be right for
Cystic Fibrosis
Karolinska University Hospital 20
Not applicableStudy completedNCT04923464
What this trial is testing

A Decentralized Study to Evaluate Physical Activity and Cough Frequency Using Wearable Technology in Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
Vertex Pharmaceuticals Incorporated 51
Early research (Phase 1)Study completedNCT04926701
What this trial is testing

A First in Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled ETD001 in Healthy Subjects

Who this might be right for
Cystic Fibrosis
Enterprise Therapeutics Ltd 98
Testing effectiveness (Phase 2)Ended earlyNCT01518595
What this trial is testing

Bosentan for Treatment of Hepatopulmonary Syndrome in Patients With Liver Cirrhosis

Who this might be right for
Hepatopulmonary SyndromeLiver Cirrhosis
Medical University of Vienna 6
Large-scale testing (Phase 3)Study completedNCT00662675
What this trial is testing

The Efficacy and Tolerability of Pancrelipase Microtablet (MT) Capsules for the Treatment of Cystic Fibrosis-dependent Exocrine Pancreatic Insufficiency

Who this might be right for
Exocrine Pancreatic InsufficiencySteatorrheaMalabsorption Syndromes+1 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 40
Not applicableStudy completedNCT02646995
What this trial is testing

Lipid Formulation to Increase the Bioavailability of Fatty Acids in Cystic Fibrosis (CF) Patients

Who this might be right for
Cystic Fibrosis
Société des Produits Nestlé (SPN) 16
Testing effectiveness (Phase 2)Study completedNCT01619657
What this trial is testing

Preventive Inhalation of Hypertonic Saline in Infants With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis Lung Disease
Heidelberg University 42
Testing effectiveness (Phase 2)Study completedNCT02136992
What this trial is testing

Clinical Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Shanghai Pulmonary Hospital, Shanghai, China 160
Not applicableActive Not RecruitingNCT03041623
What this trial is testing

Japanese Idiopathic Interstitial Pneumonias Registry

Who this might be right for
Idiopathic Interstitial Pneumonia
North East Japan Study Group 867
Not applicableStudy completedNCT04017559
What this trial is testing

Clinical Impact of MI on Inhaled Antibiotic Adherence in Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
Belfast Health and Social Care Trust 22
Not applicableLooking for participantsNCT04002882
What this trial is testing

Role of Body Fat Distribution in Metabolic and Pulmonary Decline in Cystic Fibrosis (ORBIT-CF)

Who this might be right for
Cystic Fibrosis
Emory University 90
Not applicableStudy completedNCT05074680
What this trial is testing

COVID-19 Antibody Responses In Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
Insel Gruppe AG, University Hospital Bern 5
Large-scale testing (Phase 3)Study completedNCT00909727
What this trial is testing

Study of Ivacaftor in Cystic Fibrosis Subjects Aged 6 to 11 Years With the G551D Mutation

Who this might be right for
Cystic Fibrosis
Vertex Pharmaceuticals Incorporated 52
Large-scale testing (Phase 3)Ended earlyNCT03447262
What this trial is testing

A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy

Who this might be right for
Cystic Fibrosis
Vertex Pharmaceuticals Incorporated 484
Not applicableStudy completedNCT03579173
What this trial is testing

Determinants of Early Cystic Fibrosis Lung Disease

Who this might be right for
Cystic Fibrosis in Children
Indiana University 61
Not applicableStudy completedNCT01150721
What this trial is testing

Comparing Expectorated and Induced Sputum and Pharyngeal Swabs for Cultures, AFB Smears, and Cytokines in Pulmonary Nontuberculous Mycobacterial Infection

Who this might be right for
Mycobacterium Infections, Non-tuberculous
National Institutes of Health Clinical Center (CC) 177
Testing effectiveness (Phase 2)Active Not RecruitingNCT06962852
What this trial is testing

A Long-term Study to Monitor the Health Status of People With Cystic Fibrosis Who Took Part in a Previous Study With BI 3720931 (Lenticlair™-ON)

Who this might be right for
Cystic Fibrosis
Boehringer Ingelheim 5
Not applicableUnknownNCT06184763
What this trial is testing

Evolution of the 6-minute Walk Test in Patients Treated With ELEXACAFTOR / TEZACAFTOR / IVACAFTOR

Who this might be right for
Cystic Fibrosis
Hospices Civils de Lyon 73
Not applicableStudy completedNCT02976714
What this trial is testing

Identification of Predictive Epigenetic Biomarkers of Lung Disease Severity in Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
University Hospital, Montpellier 50
Next Page